Arca Biopharma | ABIO - Operating Profit


Arca Biopharma reported $-34.43M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Alterity Therapeutics Limited AUD -8.07M 302.4K Dec/2025
Amgen USD 3.96B 464M Dec/2025
Arca Biopharma USD -34.43M 326K Dec/2025
Biogen USD 659.6M 192.2M Sep/2025
Brainstorm Cell Therapeutics USD -2.24M 197K Dec/2025
Bristol-Myers Squibb USD 4.2B 562M Dec/2025
Capricor Therapeutics USD -29.16M 2.87M Dec/2025
Cipla INR 9.77B 6.21B Dec/2025
Clal Biotechnology ILS -1.74M 7.46M Dec/2022
Compugen USD 56.04M 63.93M Dec/2025
CSL USD 2.64B 1.97B Dec/2025
Cytokinetics USD -178.37M 11.61M Dec/2025
Daiichi Sankyo JPY 89.54B 42.01B Dec/2025
Gilead Sciences USD 2.96B 551M Dec/2025
GlaxoSmithKline GBP 1.44B 1.35B Dec/2025
Grifols EUR 320.55M 91.01M Dec/2025
Laboratory Of America USD 382M 15.3M Dec/2025
Myriad Genetics USD -3M 20.3M Dec/2025
Otsuka Holdings JPY 67.25B 101.57B Dec/2025
Pfizer USD 4.65B 3.99B Dec/2025
United Therapeutics USD -14.6M 403.9M Dec/2025